Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

39 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    AkzoNobel Signs Agreement To Sell Its Shares In ICI Pakistan

    De Brauw Blackstone Westbroek has advised AkzoNobel on reaching an agreement to sell its 75.81 percent shareholding in ICI Pakistan Limited to the Yunus Brothers Group for €124.4 million (subject to a net debt and interest adjustment).
    NetherlandsFood, Drugs, Healthcare, Life Sciences
    De Brauw Blackstone Westbroek
    De Brauw Blackstone Westbroek
  • Article

    Armed Cell Therapeutics Acquires Preclinical CAR-T Portfolio From Lakefront

    Armed Cell Therapeutics BV has acquired a portfolio of preclinical CAR-T assets from Lakefront Biotherapeutics NV, with lead programs targeting non-Hodgkin lymphoma and small cell lung cancer. The acquisition includes multi-targeting and armed CAR-T constructs featuring fully human binders and human protein payloads designed to enhance CAR-T cell potency and persistence. Armed Cell's research teams in the United States and Europe are advancing these programs toward clinical development for patients with hig
    Netherlands
Corporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP
  • Article

    Amsterdam: The New Pharma Hub In Europe

    As of March 2019, Amsterdam will be the proud home of the European Medicines Agency (EMA). It's been confirmed that the EMA will relocate its headquarters from London to Amsterdam due to Brexit.
    NetherlandsFood, Drugs, Healthcare, Life Sciences
    Intertrust
    Intertrust
  • Article

    Recent European Developments Regarding Supplementary Protection Certificates (SPCs)

    The Court of Justice of the European Union again handed down some important decisions in an attempt to clarify the interpretation of Regulation 469/2009.
    European UnionIntellectual Property
    De Brauw Blackstone Westbroek
    De Brauw Blackstone Westbroek
  • Article

    Nomination Des Juges De La Juridiction Unifiée Du Brevet (JUB)

    Conformément à la feuille de route de la juridiction unifiée du brevet, la Cour unifiée du brevet a confirmé, le 19 octobre 2022, la nomination d'un total de 85 juges.
    European UnionIntellectual Property
    Novagraaf Netherlands BV
    Novagraaf Netherlands BV
  • Article

    Nautadutilh And Niaba Publish Report On Market Developments In The Dutch Biotechnology Industry

    NautaDutilh and the Netherlands Biotech Industry Association (Niaba) are pleased to inform you that we have published our report on market expectations in the Dutch biotechnology industry.
    NetherlandsFood, Drugs, Healthcare, Life Sciences
    NautaDutilh
    NautaDutilh
  • Article

    Dutch FDI Screening Set To Expand To Six New Sensitive Technology Categories

    The Netherlands is poised to dramatically expand its foreign direct investment screening regime by adding six highly sensitive technology categories—including biotechnology, artificial intelligence, and nanotechnology...
    NetherlandsGovernment, Public Sector
    Jones Day
    Jones Day
  • Article

    Nagoya Protocol Soon To Restrict Use Of Genetic Resources From Other Countries

    The ‘Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization’ will enter into force on 12 October 2014.
    NetherlandsIntellectual Property
    De Brauw Blackstone Westbroek
    De Brauw Blackstone Westbroek
  • Article

    ECJ Opens Door To SPCs For Safeners In Plant Protection Products

    The European Court of Justice has decided that a safener can fall within the definition of an ‘active substance’ as outlined in Articles 1.8 and 3 of the Plant SPC Regulation.
    European UnionFood, Drugs, Healthcare, Life Sciences
    De Brauw Blackstone Westbroek
    De Brauw Blackstone Westbroek
  • Article

    Court Of Appeal Of The Hague: One SPC Per Patent

    On 27 August 2013, the Court of Appeal of The Hague rendered a remarkable judgment in preliminary injunction proceedings between Teva and Sanofi.
    NetherlandsFood, Drugs, Healthcare, Life Sciences
    NautaDutilh
    NautaDutilh
  • Article

    Medical Devices Regulation (MDR) Entered Into Effect

    On May 26, 2021 the Medical Devices Regulation (MDR) entered into effect after a four-year transitional period.
    NetherlandsFood, Drugs, Healthcare, Life Sciences
    Loyens & Loeff
    Loyens & Loeff
  • Article

    Advocate General: The Use Of Unfertilised Human Ova Is Patentable

    The Advocate General of the European Court of Justice recently opined that parthenogenetically activated unfertilised human ova are not human embryos.
    NetherlandsIntellectual Property
    De Brauw Blackstone Westbroek
    De Brauw Blackstone Westbroek
  • Article

    SPC Waivers Explained By The District Court Of The Hague

    The case law year started well for those interested in supplementary protection certificates ("SPCs") for patents and waivers thereof: on 23 January 2024...
    NetherlandsIntellectual Property
    Taylor Wessing
    Taylor Wessing
  • Article

    AstraZeneca - CJEU's Decision Re. Abuse Of Dominant Position (Losec)

    In a judgment of 6 December 2012, the Court of Justice dismissed AstraZeneca's appeal against the General Court's decision that the company had abused its dominant position with respect to its blockbuster anti-ulcer drug, Losec.
    NetherlandsFood, Drugs, Healthcare, Life Sciences
    NautaDutilh
    NautaDutilh
  • Article

    New OECD/EUIPO Study Reveals Risk Of Counterfeits To Health, Safety And The Environment

    The joint study released in March also discusses how the COVID-19 pandemic has exacerbated existing problems by opening new opportunities for illicit trade.
    European UnionIntellectual Property
    Novagraaf Netherlands BV
    Novagraaf Netherlands BV
  • Article

    Novelty Destroying Acts In Clinical Trials

    A recently published decision of the European Patent Office’s (EPO) Board of Appeal about European patents and clinical trials provides for interesting reading and for some important pointers about how to deal with clinical trials for medicinal products but also for medical devices as to not destroy novelty of a patentable invention with invalidity as result.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Axon Lawyers
    Axon Lawyers
  • Article

    The Importance Of An Explicit Secrecy Clause In Clinical Trials

    European Patent Office, Board of Appeal, 7 July 2007, T 0007/07 (Ethinylestradiol and drospirenone for use as a contraceptive/BAYER PHARMA AG)
    NetherlandsFood, Drugs, Healthcare, Life Sciences
    Kennedy van der Laan
    Kennedy van der Laan
  • Article

    ECJ: Non-Fertilised Human Ovum Activated By Parthenogenesis Could Be Patentable

    The European Court of Justice recently ruled in International Stem Cell Corporation that parthenogenetically activated non-fertilised human ova are not human embryos.
    NetherlandsIntellectual Property
    De Brauw Blackstone Westbroek
    De Brauw Blackstone Westbroek
  • Article

    Development Of A New EMA Guideline On The Clinical Evaluation Of Ready To Use Radiopharmaceuticals[1]

    This post and the paper it links to were prepared at the instruction of Novartis; it reflects the views of the authors.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    More On Mobile Medical Apps, And On Clinical Decision Support Systems

    I have been running around a lot lately doing presentations on conferences about medical devices and software, so I though it would be useful to give you a round-up on that subject.
    NetherlandsMedia, Telecoms, IT, Entertainment
    Axon Lawyers
    Axon Lawyers
  • Showing 1–20 of 39 results

    Next
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics